Correlation Between Regeneron Pharmaceuticals and Smith Douglas

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Smith Douglas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Smith Douglas into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Smith Douglas Homes, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Smith Douglas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Smith Douglas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Smith Douglas.

Diversification Opportunities for Regeneron Pharmaceuticals and Smith Douglas

0.83

Correlation Coefficient

Regeneron Pharmaceuticals  Smith Douglas

Very poor diversification

The 3 months correlation between Regeneron and Smith is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Smith Douglas Homes in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Smith Douglas Homes and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Smith Douglas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Smith Douglas Homes has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Smith Douglas go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Smith Douglas

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.71 times more return on investment than Smith Douglas. However, Regeneron Pharmaceuticals is 1.41 times less risky than Smith Douglas. It trades about -0.14 of its potential returns per unit of risk. Smith Douglas Homes is currently generating about -0.54 per unit of risk. If you would invest  74,957  in Regeneron Pharmaceuticals on October 4, 2024 and sell it today you would lose (3,724) from holding Regeneron Pharmaceuticals or give up 4.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.45%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Smith Douglas Homes

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Smith Douglas Homes

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Smith Douglas Homes has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Regeneron Pharmaceuticals and Smith Douglas

The main advantage of trading using opposite Regeneron Pharmaceuticals and Smith Douglas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Smith Douglas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Smith Douglas will offset losses from the drop in Smith Douglas' long position.

The idea behind Regeneron Pharmaceuticals and Smith Douglas Homes pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.